-
-
-
-
-
-
-
Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
-
-
-
-
-
-
-
Myriad Genetics promotes Ben Wheeler to chief financial officer
-
-
-
-
-
-
-
Piper Sandler: 'Opportunities to Buy Dislocated Stocks after Prints'
-
-
-
-
-
-
-
Myriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the second consecutive year of double-digit revenue growth
-
-
-
-
-
-
-
Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance
-
-
-
-
-
-
-
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
-
-
-
-
-
-
-
Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
-
1,208,004 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

